节点文献

终末期肾病透析患者肌少症的发病机制及诊治进展

The pathogenesis and treatment of sarcopenia in end-stage renal disease patients on maintenance dialysis

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 万利王梅

【Author】 WAN Li;WANG Mei;Blood Purification Center, Department of Nephrology, Peking University International Hospital;Department of Nephrology, Peking University People’s Hospital;

【通讯作者】 王梅;

【机构】 北京大学国际医院肾脏内科血液净化中心北京大学人民医院肾内科

【摘要】 肌少症是以骨骼肌质量、力量以及功能降低为主要特征的退行性综合征。终末期肾病透析患者由于疾病本身、各种并发症、透析治疗及其带来的活动减少等,可加速肌肉消耗,增加肌少症的发生。透析患者合并肌少症的发生率高,死亡率高,需要早期预防、早期诊断和治疗。现就透析患者肌少症的发病机制及诊治进展进行综述。

【Abstract】 Sarcopenia is a syndrome characterized by progressive and generalized loss of skeletal muscle mass, strength and function. End-stage renal disease(ESRD) patients are at a higher risk of accelerated muscle wasting due to the renal diseases itself, various complications, dialysis treatment and reduced activity from dialysis treatment. The incidence of sarcopenia is higher in dialysis patients and the mortality will be increased in dialysis patients with sarcopenia, highlighting the great importance of early prevention, detection and treatment of muscle wasting. In this article, we summarize the pathogenesis, diagnosis and treatment of sarcopenia in ESRD patients on maintenance dialysis.

  • 【文献出处】 中国血液净化 ,Chinese Journal of Blood Purification , 编辑部邮箱 ,2023年02期
  • 【分类号】R692.5;R685
  • 【下载频次】55
节点文献中: 

本文链接的文献网络图示:

本文的引文网络